Forms

s. 56 Exemptions

Health Canada has a webpage regarding s. 56 exemptions, which can be found here. Forms for those seeking s. 56 exemptions for clinical and scientific purposes can be found via the links below.

• Application Form For An Exemption To Use A Controlled Substance For Clinical Studies

• Application Form For An Exemption To Use A Controlled Substance For Scientific Purposes

• Import Order Authorization and Permit Application Form

For more information regarding requesting s. 56 exemptions, please see our page on the subject.

Special Access Program

Regulations governing the Special Access Program were amended on January 5, 2022 to allow health practitioners to request restricted drugs like psilocybin and MDMA for patients with serious or life-threatening conditions where convention medicines have failed, or are otherwise unsuitable or not available in Canada.

Health practitioners can also request ibogaine, but Health Canada is reportedly not inclined to grant such requests.

Health Canada’s web page regarding Special Access Program requests can be found here.

Forms for requesting non-marketed drugs under the Special Access Program can be found via the links below.

• Form A - Patient specific request - C08.010(1)

• Form B - Future use request patient identity unknown C08.010 (1) and (3)

• Form C - Follow-up information further to C08.010(1)(b)(i)

• Form D - Pre-positioning request

CDS Dealer’s License

A Controlled Drugs and Substances (CDS) Dealer’s License is required to legally engage in activities, such as production and sale, of otherwise-illegal psychedelic substances such as psilocybin, MDMA, LSD, and DMT (ayahuasca).

Forms concerning CDS Dealer’s Licenses can be found via the links below.

• Application for a Controlled Drugs and Substances Dealer’s Licence

• Application for Amendment of a Controlled Drugs and Substances Dealer’s Licence

• Application for Changes Affecting Personnel in Charge